The nurse assesses the client might be experiencing toxicity from colchicine. Which statement by the client would most likely confirm the nurse's suspicion?

Correct Answer: B

Rationale: Colchicine toxicity causes GI distress-nausea, vomiting, pain-per overdose data, a hallmark sign. Joint pain is gout, not toxicity. Vision/taste changes or cramps aren't linked-GI rules. This confirms suspicion, per assessment.

Correct Answer: D

Rationale: Finasteride is an FDA-approved medication for male pattern baldness (androgenetic alopecia). It works by inhibiting the conversion of testosterone to dihydrotestosterone, which is responsible for hair follicle miniaturization. Dexamethasone (A), para-aminobenzoic acid (B), and mupirocin (C) are not used to treat hair loss.

Correct Answer: A

Rationale: When a company develops a new drug and gives it an official name, this name is the brand name. The brand name is the unique name that the company chooses to market the drug under, often for trademark purposes. It is typically a more catchy and recognizable name compared to the generic name of the drug, which is based on the drug's active ingredients. The brand name is used for marketing and promoting the drug to consumers and healthcare professionals. Examples of brand names include Advil, Tylenol, and Viagra.

Correct Answer: B

Rationale: Gout is a metabolic disorder characterized by elevated levels of uric acid in the blood, which can be exacerbated by niacin therapy. Niacin can increase uric acid levels, potentially leading to gout flare-ups in patients with a history of gout. Therefore, a history of gout would be recognized as a contraindication for beginning Niacin therapy.

Correct Answer: C

Rationale: ADHD stimulant (e.g., amphetamine) overdose (formication, dry mouth) lacks a specific antidote, but flumazenil -is listed, likely a typo for a benzo to calm agitation. Ammonium chloride , epinephrine , pilocarpine , and theophylline (E) don't fit. Benzos would address symptoms.